Search clinical trials for: Oral Sodium ferric pyrophosphate

Total 415 results

Starpharma Pty Ltd

Completed

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Bacterial Vaginosis

United States, Puerto Rico, Canada
Starpharma Pty Ltd

Completed

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Bacterial Vaginosis

United States, Bulgaria, Czechia, Hungary, Ukraine, United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy Volunteers

Healthy
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

Healthy

India
Aminu Kano Teaching Hospital
Nigerian Cardiac Society

Completed

Peripartum Cardiomyopathy in Nigeria Registry (PEACE)

Peripartum Cardiomyopathy

Nigeria
Damanhour University
Menoufia University

Unknown

Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial

Cardiomyopathies | Diabete Type 2 | Heart Failure With Reduced Ejection Fraction (HFrEF)
University Medical Center Groningen
AstraZeneca; Dutch Kidney Foundation

Enrolling by invitation

The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD

Heart Failure | Death | Kidney Disease, Chronic | Kidney Failure | Renal Transplant Failure

Netherlands, Germany, Australia
Medical University of Vienna
Attoquant Diagnostics

Completed

EMPRA (EMPagliflozin and RAs in Kidney Disease) (EMPRA)

Diabetes Mellitus, Type 2 | Diabetic Kidney Disease | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3

Austria
Boehringer Ingelheim

Completed

BI 10773 Administered as Oral Solution to Healthy Male Volunteers

Healthy
Ferring Pharmaceuticals

Completed

A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy

Bowel Preparation

United States, Canada
Procter and Gamble

Completed

Evaluation of the Anticaries Efficacy of Dentifrice Formulations Using an In-situ Model

Caries

Australia
Universitaire Ziekenhuizen KU Leuven

Completed

The Effect of Tongue Cleaning in Periodontitis Patients

Periodontitis | Tongue Coating

Belgium
Western University, Canada

Completed

Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women (RVMM)

Bacterial Vaginosis | Vulvovaginal Candidiasis

Rwanda
Emory University
American Heart Association

Completed

FFA-Induced Hypertension and Endothelial Dysfunction

Hypertension | Endothelial Dysfunction

United States
AbbVie

Completed

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Endometriosis

United States, Canada, Puerto Rico
Université de Sherbrooke
Janssen Inc.

Withdrawn

Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF) (Canacardia)

Heart Failure | Type2 Diabetes
Mount Sinai Hospital, Canada
Boehringer Ingelheim

Recruiting

Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes (EMPA post-GDM)

Gestational Diabetes

Canada
Mayo Clinic
Satiogen Pharmaceuticals, Inc.

Completed

Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

Overweight | Type 2 Diabetes Mellitus | Obese

United States
Peking Union Medical College Hospital

Unknown

A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia

Low/Intermediate Risk-1 MDS

China
University of California, San Diego
National Cancer Institute (NCI)

Withdrawn

Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer

Lymphoma | Head and Neck Cancer | Gastric Cancer | Lymphoproliferative Disorder

United States
Lexicon Pharmaceuticals

Unknown

Oral Contraceptive DDI Study

Healthy

United States
Hospital Universitari Vall d'Hebron Research Institute

Recruiting

Preoperative Oral Antibiotics With vs Without Mechanical Bowel Preparation to Reduce Surgical Site Infections Following Colonic Resection: an International Randomized Controlled Trial. (ORALEV2)

Wounds and Injuries | Surgery--Complications

Spain, Italy, China, Greece, Russian Federation, United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Active, not recruiting

DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance (DAPARESIST)

Heart Failure

United Kingdom
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5mL Under Fed Condition

Healthy

India
Fundación Pública Andaluza para la Investigación...

Unknown

SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease

Type 2 Diabetes Mellitus

Spain
Medical University of Graz
Medical University of Vienna; Johannes Kepler University of Linz; Paracelsus... and other collaborators

Completed

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction (EMMY)

Acute Myocardial Infarction

Austria
Torre Médica Santé

Completed

Microbiota Modification for the Treatment of Motor Complication of Parkinson´s Disease

Parkinson's Disease Aggravated

Mexico
Amicus Therapeutics

Completed

A Phase 1 Study To Evaluate the Safety of Migalastat Hydrochloride Given Intravenously to Healthy Volunteers

Fabry Disease

Netherlands
Saint Luke's Health System

Completed

Empagliflozin Impact on Hemodynamics in Patients With Heart Failure (EMBRACE-HF)

Heart Failure

United States
University of Erlangen-Nürnberg Medical School

Completed

Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure (ELSI)

Chronic Heart Failure

Germany
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis (PRECISION-BP)

Cardiovascular Diseases | Hypertension | Obesity | Nocturnal Blood Pressure | Natriuretic Peptides | Renin-Angiotensin-Aldosterone System

United States
Procter and Gamble

Completed

Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM) (OHMOM)

Gingivitis | Pregnancy

United States
University of Texas Southwestern Medical Center
The Rogosin Institute

Completed

Phenytoin for Memory Impairment Secondary to Megestrol

Cognitive Impairment

United States
Sheba Medical Center

Unknown

Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

Coronary Disease With Diabetes Mellitus

Israel
Tan Tock Seng Hospital

Recruiting

Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes (DMVascular)

Diabetes

Singapore
Brugmann University Hospital

Completed

Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.

Sprain

Belgium
Eyestem Research Pvt. Ltd.

Not yet recruiting

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Geographic Atrophy | Retinal Disease
SFJ Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects

Healthy

United States
PhaseBio Pharmaceuticals Inc.

Completed

Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers

Healthy

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Not yet recruiting

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease (SHIELD)

Non-Alcoholic Fatty Liver Disease
Ann & Robert H Lurie Children's Hospital of Chicago

Not yet recruiting

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease (SLIDE)

NAFLD | Non-Alcoholic Fatty Liver Disease | Pediatric NAFLD

United States
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder

Autism Spectrum Disorder (ASD)

Spain, Hungary, Poland, Brazil, France, Italy, Portugal, United Kingdom, Germany, Netherlands
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Ain Shams University
Drug Research Centre, Cairo, Egypt

Completed

The Effect of Morning Versus Evening Administration on The Pharmacokinetics and Pharmacodynamics of Empagliflozin

Diabetes Mellitus | Pharmacokinetics | Pharmacodynamics

Egypt
Beth Israel Deaconess Medical Center

Recruiting

The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Lumbar Spine Injury

United States
Kinderkrankenhaus auf der Bult

Terminated

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) (Dapa-Stress)

Type 1 Diabetes | Diabetic Ketoacidosis

Germany
Tufts Medical Center

Terminated

Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

Constipation

United States
Boehringer Ingelheim

Completed

Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon

Healthy

Germany
Food and Drug Administration (FDA)
BioPharma Services, Inc

Completed

Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets

Healthy Volunteers

United States
Centre Hospitalier Intercommunal Creteil
Merck Sharp & Dohme LLC

Completed

New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors (RANDOS)

Infertility

France

Search clinical trials for: Oral Sodium ferric pyrophosphate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations